Microaxial flow pump for high-risk PCI: are we ready for the prime time?
作者信息
Thiele Holger, Perera Divaka
机构信息
Department of Internal Medicine/Cardiology, Leipzig Heart Science, Heart Center Leipzig at Leipzig University, Leipzig, Germany.
British Heart Foundation Centre of Research Excellence at the School of Cardiovascular Medicine and Sciences, King's College London, London, United Kingdom.
出版信息
EuroIntervention. 2024 May 10;20(9):530-532. doi: 10.4244/EIJ-D-24-00044.
Abstract
摘要
相似文献
1
Microaxial flow pump for high-risk PCI: are we ready for the prime time?
EuroIntervention. 2024 May 10;20(9):530-532. doi: 10.4244/EIJ-D-24-00044.
2
Unprotected distal left main percutaneous intervention.
Prog Cardiovasc Dis. 2025 Jan-Feb;88:53-59. doi: 10.1016/j.pcad.2024.12.006. Epub 2024 Dec 31.
3
Impella device use in high-risk PCI.
EuroIntervention. 2019 Oct 20;15(8):731. doi: 10.4244/EIJ-D-19-00279L.
4
Off-Pump Coronary Artery Bypass Graft Versus Drug-Eluting Stent Implantation in Patients with Multivessel Disease Involving the Right Coronary Artery.
Thorac Cardiovasc Surg. 2019 Sep;67(6):458-466. doi: 10.1055/s-0038-1653962. Epub 2018 May 29.
5
Indication and short-term clinical outcomes of high-risk percutaneous coronary intervention with microaxial Impella® pump: results from the German Impella® registry.
Clin Res Cardiol. 2018 Aug;107(8):653-657. doi: 10.1007/s00392-018-1230-6. Epub 2018 Mar 8.
6
Revascularization in left main coronary artery disease: comparison of off-pump coronary artery bypass grafting vs percutaneous coronary intervention.
Eur J Cardiothorac Surg. 2013 Oct;44(4):718-24. doi: 10.1093/ejcts/ezt054. Epub 2013 Feb 19.
7
Hybrid revascularisation in multivessel coronary artery disease: could a combination of CABG and PCI be the best option in selected patients?
EuroIntervention. 2013 Mar;8(11):1335-41. doi: 10.4244/EIJV8I11A202.
8
Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
JACC Cardiovasc Interv. 2013 Dec;6(12):1242-9. doi: 10.1016/j.jcin.2013.08.005.
9
Demonstration of the Safety and Feasibility of Robotically Assisted Percutaneous Coronary Intervention in Complex Coronary Lesions: Results of the CORA-PCI Study (Complex Robotically Assisted Percutaneous Coronary Intervention).
JACC Cardiovasc Interv. 2017 Jul 10;10(13):1320-1327. doi: 10.1016/j.jcin.2017.03.050.
10
Revascularization in 2017: Technical and diagnostic improvements in PCI: more pieces in the puzzle.
Nat Rev Cardiol. 2018 Feb;15(2):80-82. doi: 10.1038/nrcardio.2017.205. Epub 2017 Dec 14.
本文引用的文献
1
Percutaneous Left Ventricular Unloading During High-Risk Coronary Intervention: Rationale and Design of the CHIP-BCIS3 Randomized Controlled Trial.
Circ Cardiovasc Interv. 2024 Mar;17(3):e013367. doi: 10.1161/CIRCINTERVENTIONS.123.013367. Epub 2024 Feb 27.
2
Prophylactic Mechanical Circulatory Support Use in Elective Percutaneous Coronary Intervention for Patients With Stable Coronary Artery Disease.
Circ Cardiovasc Interv. 2022 May;15(5):e011534. doi: 10.1161/CIRCINTERVENTIONS.121.011534. Epub 2022 May 17.
3
Management of cardiogenic shock.
EuroIntervention. 2021 Aug 27;17(6):451-465. doi: 10.4244/EIJ-D-20-01296.
4
A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study.
Circulation. 2012 Oct 2;126(14):1717-27. doi: 10.1161/CIRCULATIONAHA.112.098194. Epub 2012 Aug 30.
5
Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention: a randomized controlled trial.
JAMA. 2010 Aug 25;304(8):867-74. doi: 10.1001/jama.2010.1190.
Zotero 插件